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Abstract 2-n-Heptyl 4-hydroxyquinoline-N-oxide (HOQNO) 
inhibits the succinate: quinone oxidoreductase activity of isolated 
and membrane-bound succinate:menaquinone oxidoreductase of 
B. subtilis. The inhibition pattern resembles closely that observed 
for a-thenoyltrifluoroacetone and carboxins in the mitochondrial 
succinate:ubiquinone oxidoreductase: ca. 90% of the activity is 
highly sensitive to HOQNO (K; ca. 0.2 pM for the isolated 
enzyme) whereas the rest 10% proves to be resistant o the inhib- 
itor. HOQNO binding is shown to perturb the absorption spec- 
trum of the ferrous di-heme cytochrome b of the B. subtilis suc- 
cinate:quinone oxidoreductase both in the a and Sorer bands. In 
addition, the inhibitor is shown to bring about a negative shift of 
Em of the low-potential heine b. It is suggested that HOQNO 
interacts with a menasemiquinone binding site near the low-poten- 
tial heine and suppresses the MQ'--to-MQH2 step of the quinone 
reductase reaction but allows partly for the MQ- 
to-MQ'- transition to occur; dismutation of MQ" formed in the 
latter reaction to MQ and MQH 2 may account for the 10% of 
the enzyme activity insensitive to HOQNO. 
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known to be blocked specifically by a c~-thenoyltrifluoroace- 
tone (TTFA) and carboxins [1,5,6]. These inhibitors are be- 
lieved to act at the ubiquinone (UQ) reduction site, interrupting 
electron transfer between the high-potential iron-sulfur centre 
S-3 and UQ [1,7] and destabilizing the tightly bound ubisemiq- 
uinone radical [8-11]. B. subtilis SQR is not sensitive to these 
compounds but is inhibited by n-heptyl 4-hydroxyquinoline-N- 
oxide (HOQNO) [4,12]. HOQNO is a potent UQ and menaqui- 
none (MQ) antagonist acting on many respiratory cytochrome 
b containing quinone-reactive redox enzymes in various organ- 
isms. In particular, HOQNO is known as a classical inhibitor 
of the mitochondrial cytochrome bct complex [13], binding at 
the quinone reductase site of this enzyme (so-called, centre i) 
and bringing about a spectral perturbation of the high-potential 
heme b [14] and a positive shift of its Em [15]. 
In this work we have studied effects of HOQNO on the 
purified and membrane-bound B. subtilis SQR. The HOQNO 
inhibition pattern is rather similar to the effect of TTFA and 
carboxins on the mitochondrial SQR. In addition HOQNO 
perturbs the optical absorption spectrum of cytochrome b in 
SQR and brings about a negative shift of the low-potential 
heme (heme bL) of the cytochrome. Implications of these find- 
ings for the mechanism of HOQNO inhibitory action are dis- 
cussed. 
1. Introduction 
Succinate:quinone oxidoreductase from B. subtilis (SQR; 
EC 1.3.5.1) transfers reducing equivalents from succinate to 
menaquinone-7 (reviewed in [1,2]). The enzyme is an integral 
component both of the Krebs' citric acid cycle and of the 
respiratory chain. It consists of a two subunit water-soluble 
dehydrogenase part carrying a dicarboxylate binding site, one 
FAD and three iron sulfur centres, and of a membrane anchor 
subunit which is a transmembrane protein with 5 hydrophobic 
c~-helical segments spanning the phospholipid bilayer. 
The 23 kDa anchor subunit of B. subtilis SQR contains two 
tightly bound redox active protohemes with different optical, 
EPR and redox characteristics [3,4] and thus is a di-heme cyto- 
chrome b. In some other bacteria or in mitochondria from 
higher organisms, the corresponding subunit contains only one 
heme (see [2,3] for review and references). 
Activity of the mammalian mitochondrial SQR has been long 
2. Materials and methods 
Membranes were isolated from the B. subtilis SQR overproducing 
strain 3GI8/pBSD1200 grown as described before [4]. SQR was puri- 
fied from the membranes according to [4]. 
Heme content of the SQR preparation was determined from the 
pyridine hemochromogen difference spectra [16]. Protein was measured 
with Folin reagent. HOQNO (Sigma) was dissolved in twice-distilled 
ethanol. 
Optical absorption spectra were recorded in the Shimadzu UV-3000 
or UV-2101 PC spectrophotometers using semi-micro 1cm optical path- 
way cells. 
Quinone reductase activity of SQR was measured at 30°C in the 
presence of Q2 (decylubiquinone) or Q~ (both from Sigma) with 2,6- 
dichlorophenol indophenol (DCPIP) as the final electron acceptor. In 
case of experiments with membranes, 2 mM KCN was added; for more 
details, see [4]. 
Anaerobic redox titrations inthe presence of a set of redox mediators 
were carried out in 100 mM MOPS-NaOH buffer, pH 7.4, as described 
previously [4]. Data were processed in PC/AT computers with the aid 
of a program package GIM (Graphic Interactive Management) devel- 
oped by Dr. Alexander L. Drachev. 
*Corresponding author. Fax: (7) (095) 939 03 38. 
Abbreviations: DCPIE 2,6-dichlorophenolindophenol; HOQNO, 
2-n-heptyl 4-hydroxyquinoline-N-oxide; MQ, menaquinone; MOPS, 
3-(N-morpholino)propanesulfonic acid; PMS, phenazine methosulfate; 
UQ, ubiquinone; SQR, succinate:quinone oxidoreductase; TTFA, 
~-thenoyltrifluoroacet on . 
3. Results 
3.1. Inhibitory action 
Fig. 1 shows typical concentration dependence of the 
HOQNO inhibitory effect on the succinate:quinone reductase 
activity of isolated (A) and membrane-bound B. subtilis SQR 
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Fig. 1. HOQNO inhibition of the succinate: quinone oxidoreductase 
activity of isolated (A) and membrane-bound B. subtilis SQR (B). The 
measurements were carried out with 200/zM Q, (A) or 100 HM Q2 (B) 
in 50 mM KH2PO4-KOH (pH 7.4) with 20/lg/ml of sodium 2,6-dichlo- 
rophenol-indophenolate as the final electron acceptor. The enzyme was 
activated before the measurements (5 min preincubation with 20 mM 
succinate at 30°C). (A) SQR concentration, 20nM. (B) Membrane 
protein concentration, 12/.tg/ml; the reaction mixture has been supple- 
mented with 2 mM KCN. The insets in A and B give Dixon lineariza- 
tion of the inhibition curves after subtraction ofthe HOQNO-resistant 
part of the activity. 
(B). In both cases the effect is clearly biphasic. The major part 
of the activity is inhibited in a hyperbolic fashion giving linear 
Dixon plots with the apparent K~ values of 0.2 HM for the 
isolated enzyme and 0.7 HM for the membrane-bound SQR at 
pH 7.5. The remaining part of the activity is not inhibited even 
at 2040 HM HOQNO and constitutes about 10% of the overall 
rate for the isolated and membrane-bound enzyme. Such a 
biphasic inhibition pattern was observed earlier for the effects 
of a-thenoyl trifluoroacetone and carboxins on the mitochon- 
drial succinate:ubiquinone r ductase activity [5;7]. The 
HOQNO inhibitory efficiency is lower at alkaline pH, the ap- 
parent K~ value for purified SQR being about 1/IM at pH 8.5 
[3]. 
3.2. Cytochrome b spectral shift 
As shown in Fig. 2, HOQNO added to the isolated SQR 
reduced with dithionite brings about a perturbation of the cyto- 
chrome b optical absorption spectrum. In the Soret band, the 
lineshape of the HOQNO-induced difference spectrum with 
"~min  = 425 nm, 2m,x = 433 nm and At . . . .  in of ca. 5 mM-"cm 
is very similar to a red shift of the cytochrome b spectrum 
induced by this inhibitor in the mitochondrial complex bq [14]. 
This is accompanied by rather small but reproducible changes 
in the visible range dominated by increased extinction at 562 
nm. The magnitude of this response (Ae ca. 0.4 mM-'  "cm -1) is 
also close to that observed for the mitochondrial cytochrome 
b a-band [14]. Notably, the HOQNO-induced peak at 562 nm 
is rather narrow and is red-shifted with respect o the a-maxi- 
mum of the cytochrome b;such a lineshape would be consistent 
with a small increase in the Qy component of the Q00 band, 
rather than with a red shift of the overall a-peak of the cyto- 
chrome. 
The spectral effect of HOQNO suggests that the inhibitor 
binds to SQR at or near cytochrome b. Spectral characteristics 
of the two hemes at room temperature are rather similar [4] and 
at the moment we are not in a position to attribute the spectral 
perturbation i duced by HOQNO specifically to heme bH or bL. 
However, evidence for the inhibitor binding at heme bL is pro- 
vided by the results presented below. 
3.3. HOQNO-induced shift of the heme bL midpoint potent&l 
Fig. 3 shows reversible redox titrations of cytochrome b in 
isolated SQR in the absence and in the presence of HOQNO. 
The titration curve of the cytochrome in the uninhibited SQR 
shows the presence of two single-electron components (hemes 
b N and b0 with almost equal contributions to the absorbance 
at 558 nm and Em values of +65 and -96 mV at pH 7.4 which 
is in close agreement with the data in [4]. It can be seen, that 
HOQNO causes a significant negative shift of the heme bL 
midpoint potential without affecting the Em of the high-poten- 
tial heme. 
4. Discussion 
Our data on B. subtilis SQR show that HOQNO (i) inhibits 
the quinone reductase activity of both isolated and membrane- 
bound enzyme, (ii) perturbs the optical absorption spectrum of 
the di-heme cytochrome b in the enzyme and (iii) shifts the E m 
of heme bL to the negative by ca. 50 mV. The simplest explana- 
tion would be that all these effects are manifestations of the 
inhibitor binding at the same site, although more data is re- 
quired to verify this postulate. 
Notably, the HOQNO inhibition pattern observed for 
B. subtilis SQR is similar to that described for TTFA and 
carboxins in mitochondrial succinate: ubiquinone reductase. 
Like the latter two inhibitors, HOQNO blocks electron transfer 
to Q without affecting reatly the dehydrogenase activity of the 
enzyme as measured in the PMS/DCPIP assay [4], and displays 
the same peculiar biphasic concentration dependence (this 
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Fig. 2. Effect of HOQNO on the optical absorption spectrum of cytochrome b in isolated B. subtilis SQR. The sample and reference contained 
2.8 aM SQR in 100 mM MOPS-NaOH (pH 7.4) reduced with 1-2 mg of solid sodium dithionite. Baseline recorded, 40/IM HOQNO was added 
to the sample and an equal volume of ethanol to the reference, and the difference spectrum was scanned. The Soret band part of the difference spectrum 
(A) has been corrected for the contribution of HOQNO to the absorbance. 
work). It is likely that the inhibitors affect Q reduction by a 
common or at least similar mechanism. Nevertheless, B. subtilis 
SQR is not inhibited by TTFA or carboxins, whereas the mito- 
chondrial enzyme is resistant to HOQNO. It would be of great 
interest o test a nature of these differences in the enzyme 
sensitivity to the inhibitors by molecular genetics methods. 
Since HOQNO is a structural analog of MQ, the inhibitor 
binding with cytochrome b implies involvement of the latter in 
MQ binding. 
Kostyrko and co-workers [17 19] revealed a preference of 
the Q-reducing site in mitochondrial SQR for the anionic forms 
of inhibitors and concluded the ubisemiquinone binding site of 
the enzyme to be the target [19] in line with the inhibitory effect 
of TTFA and carboxins on the stable ubisemiquinone(s) EPR 
signal(s) in the mitochondrial SQR [8-10,20-22]. It is then of 
particular interest hat in B. subtilis SQR, HOQNO shifts the 
Em of heine be to the negative, i.e. binds more tightly to the 
oxidized form of bL. Since the heme ferric state bears a positive 
charge, whereas the reduced one is neutral, this may indicate 
preferential binding of the HOQNO anion which is obviously 
a close analog of the anionic form of menasemiquinone. 
We propose that in B. subtilis SQR, cytochrome b partici- 
pates in the binding and stabilization of the menasemiquinone 
anion, and that the inhibitory effect of HOQNO is due to 
interaction with cytochrome b at the MQ'- binding site at or 
near heme be, analogous to one of the two UQ'- binding sites 
in mitochondrial SQR [23,24] or the two putative MQ binding 
sites in E. coli fumarate-reductase [25]. These two sites seem to 
be arranged across the membrane [3,24,25]. Magnetic inter- 
action of ubisemiquinone(s) with the single heme b in the E. coli 
SQR (corresponding probably to heme bH of B. subtilis SQR 
[3]) has been discussed by Salerno [26] and may correspond to 
the proximal UQ °- site (with respect to the dehydrogenase part 
of SQR). The heme bL-associated HOQNO-sensitive site would 
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Fig. 3. Effect of HOQNO on the redox characteristics of the di-heme 
cytochrome b in isolated B. subtilis SQR. SQR (2.8/~M) was redox 
titrated anaerobically in the absence (,,) and presence ($) of 40/IM 
HOQNO. Redox mediators: quinhydrone, diaminodurene, PMS, 
phenazine ethosulfate, 1,2-naphthoquinone, duroquinone, 1,4- 
naphtboquinone, and anthraquinone-l,5-disulfonic acid;duroquinone 
was used at 10 ~tM, all other mediators at 50/IM. Experimental points 
have been fitted by Nernst curves for 2 non-interacting single-electron 
components with unknown midpoint potentials (Am) and contributions 
to the overall absorbance hanges at the wavelength couple used (c0. 
Computer analysis finds the best fit for the following parameters. With- 
out HOQNO: Heme bH: Em= +64 mV, c~ = 0.52; heme bE: E m = - 96 
mV, ~ = 0.48. In the presence of HOQNO." Heme bH: E m = +65 mV. 
= 0.54; heme bL: Em= -153 mV. ~ = 0.46. 
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then possibly correspond to the distal semiquinone-binding do- 
main since this heme is localized closer to the periplasmic side 
of the membrane [2,3]. The role ofcytochrome b in semiquinone 
stabilization is further corroborated by the fact that the TTFA- 
sensitive stable ubisemiquinone EPR signal observed in mito- 
chondrial membranes [8 10] is usually absent from purified 
SQR preparations depleted in cytochrome b [27]. It is tempting 
to suggest hat the so-called Q-binding proteins [28], shown to 
stabilize ubisemiquinone when added to purified mitochondrial 
SQR [27], may be in fact parts of the cytochrome b apoprotein 
which splits into two polypeptides in the mammalian enzyme. 
In the light of the above discussion, the inhibition mechanism 
of HOQNO on B. subtilis SQR could be analogous to that 
proposed for TTFA and carboxins in case of the mitochondrial 
enzyme [29]. Reacting with cytochrome b, HOQNO prevents 
MQ °- binding but does not compete as strongly with MQ. 
Accordingly, the second reduction step (semiquinone toquinol) 
of the 2-electron quinone redox transition will be fully sup- 
pressed. The first MQ~MQ °- half-reaction can still remain 
viable, although probably at a decreased rate since the product 
(menasemiquinone) is destabilized and, being unable to bind 
tightly to the enzyme, will either disproportionate o MQ and 
MQH2 or autoxidize giving rise to superoxide radicals (cf. 
[29,30]). This MQ to MQ °- transition could then account for 
the ca. 10% of the B. subtilis SQR activity resistant to HOQNO. 
Acknowledgements: This work has been supported inpart by the grants 
from the Royal Swedish Academy of Sciences and the Swedish Natural 
Science Research Council to L.H. and by Grant 12726a from the Rus- 
sian Fund for Fundamental Research to A.A.K. We gratefully ac- 
knowledge discussion of the results with Dr. V.A. Kostyrko. 
References  
[1] Ackrell, B.A.C., Johnson, M.K., Gunsalus, R.P. and Cecchini, G. 
(1992) in: Chemistry and Biochemistry of Flavoenzymes (Mueller, 
F., Ed.) Vol. 3, pp. 229 297, CRC Press, Boca Raton, FL. 
[2] Hederstedt, L. and Ohnishi, T. (1992) in: Molecular Mechanisms 
in Bioenergetics (Ernster, L., Ed.) pp. 163 198, Elsevier, Amster- 
dam. 
[3] Hagerhall, C. (1994) On the Structure and Function of Succi- 
hate :Quinone Oxidoreductase using Bacillus subtilis as 
a Model Organism, PhD Thesis, University of Lund, Lund. 
[4] Hagerhall, C., Aasa, R., von Wachenfeldt, C. and Hederstedt, L. 
(1992) Biochemistry 31, 7411 7421. 
[5] Mowery, EC., Steenkamp, D.J., Ackrell, B.A.C., Singer, T.P. and 
White, G.A. (1977) Arch. Biochem. Biophys. 178, 495-506. 
[6] Tappel, A.L. (1960) Biochem. Pharmacol. 3, 289 296. 
[7] Grivennikova, V.G. and Vinogradov, A.D. (1985) Biochemistry 
(Moscow) 50, 375-383. 
[8] Ruuge, E.K. and Konstantinov, A.A. (1976) Bophysics (Moscow) 
21,586-588. 
[9] Konstantinov, A.A. and Ruuge, E.K. (1977) FEBS Lett. 81, 137- 
141. 
[10] Ingledew, W.J. and Ohnishi, T. (1977) Biochem. J. 164, 617 620. 
[11] Salerno, J.C. and Ohnishi, T. (1980) Biochem. J. 192, 769-781. 
[12] Lemma, E., Hagerhall, C., Geisler, V., Brandt, U., von Jagow, G. 
and Kroger, A. (1991) Biochim. Biophys. Acta 1059, 281-285. 
[13] Kaniuga, Z., Bryla, J. and Slater, E.C. (1969) in: Inhibitors, Tools 
in Cell Research (Bucher, Th. and Sies, H., Eds.) pp. 282-300, 
Springer, Heidelberg. 
[14] Kamensky, Y., Konstantinov, A.A., Kunz, W.S. and Surkov, S. 
(1985) FEBS Lett. 181, 95-99. 
[15] Kunz, W.S. and Konstantinov, A.A. (1983) FEBS Lett. 155, 237 
240. 
[16] Falk, J.E. (1964) Biochim. Biophys. Acta Library Vol. 2, p. 241, 
Elsevier, Amsterdam. 
[17] Kostyrko, V.A. and Yaguzhinskij, L.S. (1979) Biochemistry 
(Moscow) 44, 1884-1890. 
[18] Gavrilova, A.R., Ratnikova, L.A., Kostyrko, V.A. and 
Yaguzhinskij, L.S. (1981) Biochemistry (Moscow) 46, 1315-1320. 
[19] Afanasyeva, E.V. and Kostyrko, V.A. (1986) Biochemistry 
(Moscow) 51, 823-829. 
[20] Tikhonov, A.N., Burbaev, D.S., Grigolava, I.V., Konstantinov, 
A.A., Ksenzenko, M.Y. and Ruuge, E.K. (1977) Biophysics 
(Moscow) 22, 734-737. 
[21] Wei, Y.-H., Scholes, C.E and King, T.E. (1981) Biochem. Bio- 
phys. Res. Commun. 99, 1411-1419. 
[22] Grigolava, I.V., Konstantinov, A.A., Ksenzenko, M.Y., 
Tikhonov, A.N. and Ruuge, E.K. (1982) Biochemistry (Moscow) 
47, 1970-1982. 
[23] Ruzicka, F.J., Beinert, H., Schefler, K.L., Dunham, W.R. and 
Sands, R.H. (1975) Proc. Natl. Acad. Sci. USA 72, 288(~2890. 
[24] Salerno, J.C., Harmon, H.J., Blum, H., Leigh, J.S. and Ohnishi, 
T. (1977) FEBS Lett. 82, 179 182. 
[25] Westenberg, D., Gunsalus, R.P., Ackrell, B.A., Sices, H. and 
Cecchini, G. (1993) J. Biol. Chem. 268, 815-822. 
[26] Salerno, J. (1991) Biochem. Soc. Trans. 19, 599-605. 
[27] Xu, Y., Salerno, J.C., Wei, Y.H. and King, T.E. (1987) Biochem. 
Biophys. Res. Commun. 144, 315-322. 
[28] Yu, C.-A. and Yu, L. (1981) Biochim. Biophys. Acta 639, 99-128. 
[29] Trumpower, B.L. and Simmons, Z. (1979) J. Biol. Chem. 254, 
46084616. 
[30] Yu, L., McCurley, J.P. and Yu, C.-A. (1987) Biochim. Biophys. 
Acta 893, 75-82. 
